Driscoll Frederick W - Insider Stock Trading - OpenInsider

CIK: 1129890 - Address: C/O Cue Biopharma, Inc., 40 Guest Street, Boston, MA 02135

13 results

TC	Stat	Stk	Ins	Fil	+d	+w	+m	+q	+h	+y	avg
P	%ret	3	1	4	1	8	26	38	57	10	23
P	%wins				50	75	75	75	75	50	67
S	%ret	1	1	2	5	-1	13	0	0	0	6
S	%wins				0	100	50				50

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	L	Qty	oc	Own	H	r2y	r1y	r6m	r3m	r6w	r3w	r7d	r3d	f1d	f1w	f1m	f3m	f6m	f1y
9/7/21 16:01	9/3/21	CLRB	Cellectar Biosciences, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Driscoll Frederick W	NJ	D		P	20	1.04	0	19	New	19	D
2/24/21 12:08	2/23/21	MEIP	Mei Pharma, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Driscoll Frederick W	CA	D		S	-101	4.03	0	-25	-40	38	D
8/13/20 16:31	8/11/20	NK	Nantkwest, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Driscoll Frederick W	CA	D		S	-668	10.23	0	-65	-37	109	D
12/20/19 12:56	12/19/19	MEIP	Mei Pharma, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Driscoll Frederick W	CA	D		P	100	1.60	0	63	New	63	D
3/24/17 16:24	3/23/17	FLXN	Flexion Therapeutics Inc	DE	Health	Drug	Pharmaceutical Preparations	Driscoll Frederick W	MA	O	CFO	M.d	24	7.89	18	3	63	8	D	6	203	51	41	41	24	32	26	7	-1	-4
3/24/17 16:24	3/23/17	FLXN	Flexion Therapeutics Inc	DE	Health	Drug	Pharmaceutical Preparations	Driscoll Frederick W	MA	O	CFO	S.d	-69	23.00	18	-3	-28	8	D	6	203	51	41	41	24	32	26	7	-1	-4
3/2/17 16:56	2/28/17	FLXN	Flexion Therapeutics Inc	DE	Health	Drug	Pharmaceutical Preparations	Driscoll Frederick W	MA	O	CFO	M.d	237	7.89	5	30		8	D	-10	116	21	16	8	12	6	6	2	-1	30
3/2/17 16:56	2/28/17	FLXN	Flexion Therapeutics Inc	DE	Health	Drug	Pharmaceutical Preparations	Driscoll Frederick W	MA	O	CFO	S.d	-668	19.97	5	-33	-81	8	D	-10	116	21	16	8	12	6	6	2	-1	30
5/18/16 17:23	5/17/16	FLXN	Flexion Therapeutics Inc	DE	Health	Drug	Pharmaceutical Preparations	Driscoll Frederick W	MA	O	CFO	P	25	9.87	2	3	42	8	D	-24	-50	-44	-26	-22	-10	-2	12	-5	14	38	78	112
5/17/16 18:12	5/16/16	FLXN	Flexion Therapeutics Inc	DE	Health	Drug	Pharmaceutical Preparations	Driscoll Frederick W	MA	O	CFO	P	23	9.19	2	3	73	6	D	-25	-48	-43	-11	-12	-20	-4	3	7	10	43	85	124
8/11/11 09:11	8/9/11	NVAX	Novavax Inc	DE	Health	BioPrd	Biological Products, (No Diag	Driscoll Frederick W	MD	O	VP,CFO,T	P	24	1.18	1	20	New	20	D	-74	-42	-45	-46	-38	-41	-32	-14	6	10	37	26	13	58
11/28/07 16:33	11/28/07	GNLB	Genelabs Technologies Inc /ca	CA	Health	Drug	Pharmaceutical Preparations	Driscoll Frederick W	CA	O	CFO	P	10	1.45	0	7	New	7	D
5/21/04 11:15	5/20/04	OXGN	Oxigene Inc	DE	Health	BioPrd	Biological Products, (No Diag	Driscoll Frederick W	MA	DO	P,CEO	P.a	15	7.31	0	2	5	42	D		178	-26	-24	-19	-12	-10	-12	-3	-2	-14	-36	-23	-39

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

Return to top

Contact